The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.

 
Web www.patentalert.com

< 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

> HCV variants
~ 00458